{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:42:18Z","timestamp":1792701738124,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R03HS022342"],"award-info":[{"award-number":["R03HS022342"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.062","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T16:30:10Z","timestamp":1478536210000},"page":"6243-6249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrew D.","family":"Wiese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward F.","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.062_b0005","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/522996","article-title":"Diagnosis and management of parapneumonic effusions and empyema","volume":"45","author":"Sahn","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.062_b0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/09059180.00005610","article-title":"Empyema thoracis: new insights into an old disease","volume":"19","author":"Brims","year":"2010","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.vaccine.2016.10.062_b0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-014-2062-6","article-title":"Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology","volume":"33","author":"Fletcher","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.062_b0020","first-page":"992","article-title":"Pneumonia and empyema: causal, casual or unknown","volume":"7","author":"McCauley","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.vaccine.2016.10.062_b0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MCP.0b013e328338c19f","article-title":"Influence of pneumococcal vaccine on the incidence of empyema","volume":"16","author":"Munoz-Almagro","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.10.062_b0030","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2016.10.062_b0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.2010.156406","article-title":"Emergence of parapneumonic empyema in the USA","volume":"66","author":"Grijalva","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2016.10.062_b0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.062_b0045","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/INF.0b013e318232ee3e","article-title":"Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era","volume":"30","author":"Ampofo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.062_b0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JCM.01200-09","article-title":"Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah","volume":"48","author":"Byington","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.10.062_b0055","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2014.02.096","article-title":"Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults","volume":"32","author":"Grabenstein","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.062_b0060","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.10.062_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2016.05.009","article-title":"Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests","volume":"116","author":"Krenke","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.vaccine.2016.10.062_b0070","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/archdischild-2012-301790","article-title":"Emergence of pneumococcal 19A empyema in UK children","volume":"97","author":"Thomas","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.10.062_b0075","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3201\/eid1710.101825","article-title":"Bacterial causes of empyema in children, Australia, 2007\u20132009","volume":"17","author":"Strachan","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.062_b0080","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2010.137802","article-title":"Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997\u20132008","volume":"65","author":"Koshy","year":"2010","journal-title":"Thorax"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2016.10.062_b0085","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1016\/j.vaccine.2011.06.096","article-title":"Pneumococcal disease manifestation in children before and after vaccination: what\u2019s new?","volume":"29","author":"Andrade","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.062_b0090","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1016\/j.vaccine.2014.04.089","article-title":"Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia","volume":"32","author":"Cremers","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.062_b0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.15585\/mmwr.mm6433a1","article-title":"National, state, and selected local area vaccination coverage among children aged 19\u201335 months - United States, 2014","volume":"64","author":"Hill","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.10.062_b0100","unstructured":"National, state, and local area vaccination coverage among children aged 19\u201335 months - United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58:921\u20136."},{"key":"10.1016\/j.vaccine.2016.10.062_b0105","unstructured":"The healthcare cost and utilization project, overview of the nationwide inpatient sample. Agency for Healthcare Research and Quality."},{"key":"10.1016\/j.vaccine.2016.10.062_b0110","unstructured":"National population estimates. U.S. Census Bureau."},{"key":"10.1016\/j.vaccine.2016.10.062_b0115","first-page":"256","article-title":"Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood","volume":"6","author":"Shah","year":"2011","journal-title":"J Hosp Med Off Publ Soc Hosp Med"},{"key":"10.1016\/j.vaccine.2016.10.062_b0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/oxfordjournals.aje.a009804","article-title":"Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies","volume":"149","author":"Guevara","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.10.062_b0125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamapediatrics.2013.186","article-title":"Identifying pediatric community-acquired pneumonia hospitalizations: accuracy of administrative billing codes","volume":"167","author":"Williams","year":"2013","journal-title":"JAMA Ped"},{"key":"10.1016\/j.vaccine.2016.10.062_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.10.062_b0135","unstructured":"Papanicolaou A. Taylor approximation and the delta method. Stanford University; 2009."},{"key":"10.1016\/j.vaccine.2016.10.062_b0140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciu348","article-title":"Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine","volume":"59","author":"Pelton","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2016.10.062_b0145","first-page":"995","article-title":"Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998\u20132012","volume":"63","author":"Griffin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.10.062_b0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.062_b0155","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance","volume":"32","author":"Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.062_b0160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jamapediatrics.2015.0612","article-title":"Invasive pneumococcal disease following the introduction of 13-valent conjugate vaccine in children in New York City from 2007 to 2012","volume":"169","author":"Farnham","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2016.10.062_b0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/INF.0b013e31827e8594","article-title":"Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011","volume":"32","author":"Picazo","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.062_b0170","first-page":"1","article-title":"Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine","author":"Syrogiannopoulos","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.vaccine.2016.10.062_b0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2014-306525","article-title":"Has the incidence of empyema in Scottish children continued to increase beyond 2005?","volume":"100","author":"Nath","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.10.062_b0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jinf.2015.06.011","article-title":"Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England","volume":"71","author":"Saxena","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.10.062_b0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2213-2600(14)70032-3","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis","volume":"2","author":"Simonsen","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2016.10.062_b0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","article-title":"Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema","volume":"30","author":"Blaschke","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.062_b0195","unstructured":"Witt WP, Weiss AJ, Elixhauser A. Overview of hospital stays for children in the United States, 2012: statistical brief #187. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014."},{"key":"10.1016\/j.vaccine.2016.10.062_b0200","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/BPO.0000000000000633","article-title":"Changes in the treatment of pediatric femoral fractures: 15-year trends from United States Kids\u2019 Inpatient Database (KID) 1997 to 2012","volume":"36","author":"Naranje","year":"2016","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.vaccine.2016.10.062_b0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2014.08.024","article-title":"Long-term changes in crash rates after introduction of a Graduated Driver Licensing decal provision","volume":"48","author":"Curry","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2016.10.062_b0210","unstructured":"Vital signs: unintentional injury deaths among persons aged 0\u201319 years - United States, 2000\u20132009. MMWR Morbidity and mortality weekly report. 2012; 61: 270\u20136."},{"key":"10.1016\/j.vaccine.2016.10.062_b0215","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/TA.0000000000000399","article-title":"Trends in Alabama teen driving death and injury","volume":"77","author":"Monroe","year":"2014","journal-title":"J Trauma Acute Care Surgery"},{"key":"10.1016\/j.vaccine.2016.10.062_b0220","doi-asserted-by":"crossref","first-page":"e869","DOI":"10.3928\/01477447-20151002-52","article-title":"National trends in operative treatment of pediatric fractures in the ambulatory setting","volume":"38","author":"Bernstein","year":"2015","journal-title":"Orthopedics"},{"key":"10.1016\/j.vaccine.2016.10.062_b0225","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jpeds.2015.08.017","article-title":"Medial epicondyle fractures in children and adolescents: shifting care from general hospitals to children\u2019s hospitals?","volume":"167","author":"Fabricant","year":"2015","journal-title":"J Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T23:20:50Z","timestamp":1536276050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16309975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":45,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16309975"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}